Receptor activator of nuclear factor-κB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues

Free Radical Biology and Medicine

Volumn 47, Issue 2, 2009, Pages 189-199

  Sasaki, Hideyuki ^a   Yamamoto, Hironori ^a   Tominaga, Kumiko ^a   Masuda, Kiyoshi ^a   Kawai, Tomoko ^a   Teshima Kondo, Shigetada ^a   Matsuno, Kuniharu ^b   Yabe Nishimura, Chihiro ^b   Rokutan, Kazuhito ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Free radicals; NADPH oxidases; Osteoclast differentiation; RANKL; Reactive oxygen species

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P22; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; MACROPHAGES; MICE; MICE, KNOCKOUT; MONOCYTES; NADPH OXIDASE; OSTEOCLASTS; PROTEIN ISOFORMS; RANK LIGAND; REACTIVE OXYGEN SPECIES; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

MUS;

EID: 67349083947     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.04.025     Document Type: Article

References (31)

1. Vaananen H.K., and Laitala-Leinonen T. Osteoclast lineage and function. Arch. Biochem. Biophys. 473 (2008) 132-138
2. Key Jr. L.L., Ries W.L., Taylor R.G., Hays B.D., and Pitzer B.L. Oxygen derived free radicals in osteoclasts: the specificity and location of the nitroblue tetrazolium reaction. Bone 11 (1990) 115-119
3. Yang S., Ries W.L., and Key Jr. L.L. Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts. Calcif. Tissue Int. 63 (1998) 346-350
4. Garrett R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., and Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85 (1990) 632-639
5. Steinbeck M.J., Appel Jr. W.H., Verhoeven A.J., and Karnovsky M.J. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J. Cell Biol. 126 (1994) 765-772
6. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
7. Bedard K., and Krause K.H. The Nox family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007) 245-313
8. Lambeth J.D., Kawahara T., and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43 (2007) 319-331
9. phox in the regulated production of superoxide by phagocytes. J. Immunol. 171 (2003) 299-306
10. phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279 (2004) 45935-45941
11. Rousselle A.V., and Heymann D. Osteoclastic acidification pathways during bone resorption. Bone 30 (2002) 533-540
12. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., Kim N., and Lee S.Y. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106 (2005) 852-859
13. Yang S., Madyastha P., Bingel S., Ries W., and Key L.A. new superoxide-generating oxidase in murine osteoclasts. J. Biol. Chem. 276 (2001) 5452-5458
14. Yang S., Zhang Y., Ries W., and Key L. Expression of Nox4 in osteoclasts. J. Cell. Biochem. 92 (2004) 238-248
15. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., Takai S., Yamanishi K., Miyazaki M., Matsubara H., and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
16. Gavazzi G., Banfi B., Deffert C., Fiette L., Schappi M., Herrmann F., and Krause K.H. Decreased blood pressure in Nox1-deficient mice. FEBS Lett. 580 (2006) 497-504
17. 3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J. Biol. Chem. 278 (2003) 31756-31765
18. Pollock J.D., Williams D.A., Gifford M.A., Li L.L., Du X., Fisherman J., Orkin S.H., Doerschuk C.M., and Dinauer M.C. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9 (1995) 202-209
19. 3 selectively induces bone formation. Proc. Natl. Acad. Sci. USA 99 (2002) 13487-13491
20. Kawahara T., Kuwano Y., Teshima-Kondo S., Takeya R., Sumimoto H., Kishi K., Tsunawaki S., Hirayama T., and Rokutan K. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. J. Immunol. 172 (2004) 3051-3058
21. Lean J.M., Jagger C.J., Kirstein B., Fuller K., and Chambers T.J. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146 (2005) 728-735
22. Koh J.M., Lee Y.S., Kim Y.S., Kim D.J., Kim H.H., Park J.Y., Lee K.U., and Kim G.S. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J. Bone Miner. Res. 21 (2006) 1003-1011
23. Madyastha P.R., Yang S., Ries W.L., and Key Jr. L.L. IFN-γ enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. J. Interferon Cytokine Res. 20 (2000) 645-652
24. Yang S., Madyastha P., Ries W., and Key L.L. Characterization of interferon gamma receptors on osteoclasts: effect of interferon gamma on osteoclastic superoxide generation. J. Cell. Biochem. 84 (2002) 645-654
25. phox promoter. J. Biol. Chem. 271 (1996) 18203-18210
26. Wong B.R., Rho J., Arron J., Robinson E., Orlinick J., Chao M., Kalachikov S., Cayani E., Bartlett III F.S., Frankel W.N., Lee S.Y., and Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272 (1997) 25190-25194
27. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95 (1998) 3597-3602
28. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., and Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
29. Feng X. Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene 350 (2005) 1-13
30. Bax B.E., Alam A.S., Banerji B., Bax C.M., Bevis P.J., Stevens C.R., Moonga B.S., Blake D.R., and Zaidi M. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem. Biophys. Res. Commun. 183 (1992) 1153-1158
31. Ha H., Kwak H.B., Lee S.W., Jin H.M., Kim H.M., Kim H.H., and Lee Z.H. Reactive oxygen species mediate RANK signaling in osteoclasts. Exp. Cell Res. 301 (2004) 119-127